Skip to main content
. 2017 Jun 1;102(8):2950–2961. doi: 10.1210/jc.2017-00867

Figure 1.

Figure 1.

Plasma ALT levels over time in patients not taking a statin (white squares), those receiving statins from enrollment (black dots), and those newly started on a statin during the study (dotted line). Patients were divided according to their original randomization to (a) pioglitazone or (b) placebo. PIO, pioglitazone.